News & Insights

Learn more about how frequent, reliable, longitudinal monitoring of discrete brain functions can accelerate CNS clinical trials and improve decision-making.

 

ISCTM 2026 Data Presented

5 min read

Cumulus Neuroscience Presents Data at ISCTM 2026 Autumn Conference

Picture of Cumulus Cumulus: 17 September, 2026
Neurodegeneration Data Presentations 2026
Read More

1 min read

Cumulus Neuroscience to Present Data at ISCTM 2026 Autumn Conference

Picture of Cumulus Cumulus: 11 September, 2026
Neurodegeneration Data Presentations 2026
Read More

4 min read

Publication in Scientific Reports: Longitudinal cognitive assessment using the Cumulus NeuLogiq Platform in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Picture of Cumulus Cumulus: 18 August, 2026
Clinical Studies Neurodegeneration Publications 2026
Read More
AAIC 2026 logo

3 min read

Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment

Picture of Cumulus Cumulus: 15 July, 2026
Neurodegeneration Data Presentations 2026
Read More
AAIC 2026 logo

3 min read

Cumulus Neuroscience to Present Data at AAIC 2026 Showing a Brief Digital Symbol-Coding Task Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment

Picture of Cumulus Cumulus: 8 July, 2026
Neurodegeneration Data Presentations 2026
Read More
NeuLogiq and Muse logos

2 min read

Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials

Picture of Cumulus Cumulus: 6 July, 2026
Neuropsychiatry Neurodegeneration 2026 Sleep
Read More
Frontiers in Digital Health Publication

5 min read

Publication in Frontiers in Digital Health: The NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia

Picture of Cumulus Cumulus: 30 June, 2026
Clinical Studies Neurodegeneration Publications 2026
Read More
ASCP logo

4 min read

NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder

Picture of Cumulus Cumulus: 28 May, 2026
Clinical Studies Neuropsychiatry Data Presentations 2026
Read More
Shionogi logo

2 min read

Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.

Picture of Cumulus Cumulus: 10 February, 2026
Clinical Studies Neurodegeneration 2026
Read More
Ricardo Sáinz Fuertes, MD

2 min read

Cumulus Neuroscience Appoints Ricardo Sáinz Fuertes, MD as New Board Chair

Picture of Cumulus Cumulus: 8 January, 2026
Appointments 2026
Read More
1 2 3 4 Next